đ CVS Health Initiated, Lumentum Upgraded, Netflix Downgraded and moreâŠ
RJ Hamster
Advertisements
Ratings changes for ContraFect, GlycoMimetics, AstroNova, Coinbase Global, Apple, Zebra Technologies, Lumentum and moreâŠText âMarketBeatâ to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More. Unsubscribe.
VIEW MY PORTFOLIO
December 22nd, 2023
 Â
Forget NVDA. Buy this A.I. stock instead (ad)
Dozens of 100% â 1,000% opportunities over the last decade have led to this one under-the-radar A.I. stockâŠ
If youâre looking for an INCREDIBLE deal on stocks with huge growth potential, now is the time to look at this list our team prepared.
(**By clicking the link you are subscribing to the Summa Money Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
Apple (NASDAQ:AAPL) had its price target raised by analysts at Needham & Company LLC (Â Â Â Â ) from $195.00 to $220.00. They now have a âbuyâ rating on the stock. This represents a 13.4% upside from the current price of $194.03.
Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Needham & Company LLC (Â Â Â Â ) from $160.00 to $175.00. They now have a âbuyâ rating on the stock. This represents a 13.9% upside from the current price of $153.66.
CEO Sundar Pichai sold 22,500 shares of the businessâs stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $141.43, for a total value of $3,182,175.00. Following the sale, the chief executive officer now directly owns 2,407,688 shares of the companyâs stock, valued at approximately $340,519,313.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
insider Jennifer Newstead sold 566 shares of the companyâs stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $345.65, for a total transaction of $195,637.90. Following the transaction, the insider now owns 38,116 shares of the companyâs stock, valued at $13,174,795.40. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Analog Devices (NASDAQ:ADI) was upgraded by analysts at Edward Jones from a âholdâ rating to a âbuyâ rating.The current price is $197.59.
Lumentum (NASDAQ:LITE) was upgraded by analysts at Craig Hallum from a âholdâ rating to a âbuyâ rating.The current price is $53.27.
Waste Management (NYSE:WM) was upgraded by analysts at Erste Group Bank AG from a âholdâ rating to a âbuyâ rating.The current price is $177.38.
AIâs Explosion: Tap into the Next Trillion-Dollar Wave! (ad)
AI stocks have soared, and the sectorâs potential is just starting. By 2030, anticipate a seismic $2 trillion shift. Our special report reveals the Top 5 AI Stocks you must watch. Navigate the future of wealth.
AlloVir (NASDAQ:ALVR) was downgraded by analysts at JPMorgan Chase & Co. from an âoverweightâ rating to an âunderweightâ rating.The current price is $0.79.
AlloVir (NASDAQ:ALVR) was downgraded by analysts at Piper Sandler from an âoverweightâ rating to a âneutralâ rating.The current price is $0.79.
AlloVir (NASDAQ:ALVR) was downgraded by analysts at SVB Leerink LLC from an âoutperformâ rating to a âmarket performâ rating.The current price is $0.79.
Cingulate (NASDAQ:CING) was downgraded by analysts at Laidlaw from a âbuyâ rating to a âholdâ rating.The current price is $2.05.
LianBio (NASDAQ:LIAN) was downgraded by analysts at Jefferies Financial Group Inc. from a âbuyâ rating to a âholdâ rating. They now have a $4.00 price target on the stock, down previously from $7.00. This represents a 9.9% downside from the current price of $4.44.
Netflix (NASDAQ:NFLX) was downgraded by analysts at DZ Bank AG from a âbuyâ rating to a âholdâ rating. They now have a $495.00 price target on the stock. This represents a 0.8% upside from the current price of $491.28.
The early bird gets the worm and the options trader who waits until 9:30EST can win big! Hi, Iâm Dave Aquino and if youâre new to options trading, my e-book âHow To Master the Retirement Tradeâ will show you exactly how to take advantage of this early morning, profitable, but often overlooked window of trading time.
Altair Engineering (NASDAQ:ALTR) is now covered by analysts at JPMorgan Chase & Co.. They set an âoverweightâ rating and a $86.00 price target on the stock. This represents a 7.0% upside from the current price of $80.37.
Apollo Medical (NASDAQ:AMEH) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $41.00 price target on the stock. This represents a 9.4% upside from the current price of $37.47.
Biohaven (NYSE:BHVN) is now covered by analysts at HC Wainwright. They set a âbuyâ rating and a $50.00 price target on the stock. This represents a 24.1% upside from the current price of $40.28.
CVS Health (NYSE:CVS) is now covered by analysts at HSBC Holdings plc. They set a âbuyâ rating and a $94.00 price target on the stock. This represents a 19.2% upside from the current price of $78.89.
F&G Annuities & Life (NYSE:FG) is now covered by analysts at Piper Sandler. They set a âneutralâ rating and a $48.00 price target on the stock. This represents a 7.1% upside from the current price of $44.81.
GlycoMimetics (NASDAQ:GLYC) is now covered by analysts at Capital One Financial Co.. They set an âoverweightâ rating and a $12.00 price target on the stock. This represents a 387.8% upside from the current price of $2.46.
Keurig Dr Pepper (NASDAQ:KDP) is now covered by analysts at HSBC Holdings plc. They set a âholdâ rating and a $37.00 price target on the stock. This represents a 12.9% upside from the current price of $32.78.
Kura Oncology (NASDAQ:KURA) is now covered by analysts at Mizuho. They set a âbuyâ rating and a $26.00 price target on the stock. This represents a 88.7% upside from the current price of $13.78.
MSCI (NYSE:MSCI) is now covered by analysts at Edward Jones. They set a âbuyâ rating on the stock.The current price is $559.72.
Syndax Pharmaceuticals (NASDAQ:SNDX) is now covered by analysts at Mizuho. They set a âbuyâ rating and a $45.00 price target on the stock. This represents a 112.1% upside from the current price of $21.22.
Walgreens Boots Alliance (NASDAQ:WBA) is now covered by analysts at HSBC Holdings plc. They set a âholdâ rating and a $27.00 price target on the stock. This represents a 2.2% upside from the current price of $26.42.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeatâs free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (thatâs you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.